ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Study Comparing CT Scan and Stress Test in Diagnosing Coronary Artery Disease in Patients Hospitalized for Chest Pain (PROSPECT)

This study is currently recruiting participants.
Verified by Montefiore Medical Center, September 2008

Sponsors and Collaborators: Montefiore Medical Center
American Heart Association
Albert Einstein College of Medicine of Yeshiva University
Information provided by: Montefiore Medical Center
ClinicalTrials.gov Identifier: NCT00705458
  Purpose

The purpose of this study is to determine whether coronary artery CT scanning or nuclear stress testing is better at diagnosing chest pain patients with coronary artery disease to select appropriate candidates for coronary catheterization and re-vascularization.


Condition Intervention
Coronary Artery Disease
Angina Pectoris
Unstable Angina
Acute Coronary Syndrome
Procedure: Coronary Computed Tomography Angiography
Procedure: Stress Nuclear Myocardial Perfusion Imaging

MedlinePlus related topics:   Angina    CT Scans    Chest Pain    Coronary Artery Disease    Nuclear Scans    Stress   

ChemIDplus related topics:   Metoprolol    Metoprolol fumarate    Metoprolol succinate    Metoprolol Tartrate    Dobutamine    Dobutamine hydrochloride    Dobutamine lactobionate    Dobutamine tartrate    Adenosine   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Diagnostic, Randomized, Single Blind (Outcomes Assessor), Parallel Assignment, Safety/Efficacy Study
Official Title:   A Randomized Trial Comparing Multi-Detector Coronary CT Angiography and Stress Myocardial Perfusion Imaging as the Initial Test for the Diagnosis of Coronary Artery Disease in Intermediate Risk Patients Admitted for Chest Pain

Further study details as provided by Montefiore Medical Center:

Primary Outcome Measures:
  • Coronary catheterization that does not lead to re-vascularization [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Length of Hospital Stay (time to discharge) [ Time Frame: hosptial discharge ] [ Designated as safety issue: No ]
  • Non-fatal myocardial infarction [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
  • Death (all cause) [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
  • Post-test renal dysfunction [ Time Frame: hospital discharge ] [ Designated as safety issue: Yes ]

Estimated Enrollment:   400
Study Start Date:   July 2008
Estimated Study Completion Date:   June 2011
Estimated Primary Completion Date:   June 2011 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
CTA: Experimental
Initial EKG-gated computed tomography angiography of the coronary arteries
Procedure: Coronary Computed Tomography Angiography
64-detector, retrospectively EKG-gated, computed tomography angiography of the coronary arteries during heart rate control (intravenous metoprolol, when necessary)
MPI: Active Comparator
Initial nuclear stress myocardial perfusion imaging
Procedure: Stress Nuclear Myocardial Perfusion Imaging
Usually dual-isotope perfusion imaging at rest (201-Thallium) and at stress (99m-Technetium-MIBI). Some patients will have a 2-day MIBI protocol. Gated SPECT and attenuation-correction images will be obtained. Treadmill stress will be performed. If a patient is unable to exercise, adenosine or dobutamine will be given.

  Eligibility
Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • patient admitted for chest pain or pressure
  • patient at intermediate short term risk of MI or death (AHA/ACC guidelines)

Exclusion Criteria:

  • prior diagnosis of coronary artery disease
  • evidence of ongoing myocardial infarction (and other high risk criteria per AHA/ACC guidelines)
  • contraindications to EKG-gated CT scanning with iodinated intravenous contrast under beta-blockade
  • pregnancy
  • presence of an implanted pacemaker or defibrillator
  • stress myocardial perfusion imaging, coronary CTA or coronary catheterization within the last 6 months
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00705458

Contacts
Contact: Linda B Haramati, MD, MS     718-920-7458     lharamati@aecom.yu.edu    

Locations
United States, New York
Moses Division, Montefiore Medical Center     Recruiting
      Bronx, New York, United States, 10467

Sponsors and Collaborators
Montefiore Medical Center
American Heart Association
Albert Einstein College of Medicine of Yeshiva University

Investigators
Study Director:     Linda B Haramati, MD, MS     Montefiore Medical Center / Albert Einstein College of Medicine    
Principal Investigator:     Jeffrey M Levsky, MD, PhD     Montefiore Medical Center / Albert Einstein College of Medicine    
  More Information


Responsible Party:   Montefiore Medical Center ( Linda B. Haramati, MD, MS / Division Chief of Cardiothoracic Radiology )
Study ID Numbers:   MMC-07-07-197
First Received:   June 24, 2008
Last Updated:   September 19, 2008
ClinicalTrials.gov Identifier:   NCT00705458
Health Authority:   United States: Institutional Review Board

Keywords provided by Montefiore Medical Center:
stress myocardial perfusion imaging  
coronary computed tomography angiography  

Study placed in the following topic categories:
Arterial Occlusive Diseases
Heart Diseases
Myocardial Ischemia
Angina Pectoris
Vascular Diseases
Stress
Pain
Arteriosclerosis
Ischemia
Metoprolol
Dobutamine
Chest Pain
Coronary Disease
Signs and Symptoms
Metoprolol succinate
Acute Coronary Syndrome
Adenosine
Angina, Unstable
Coronary Artery Disease

Additional relevant MeSH terms:
Pathologic Processes
Disease
Syndrome
Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 23, 2008




Links to all studies - primarily for crawlers